ESR1 and breast carcinoma: In breast cancer (BC), the discovery that the estrogen receptor α (ERα), the main hallmark of luminal-like hormone-responsive BC subtype, acts as a non-canonical RBP, brought out a new oncogenic signature under the control of this factor [4].